AI Summary
We reviewed 374 live results for lucitofa 5 mg and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Pharmaceuticals and Rheumatology.
We reviewed 374 live results for lucitofa 5 mg and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Pharmaceuticals and Rheumatology.
Source: Lucius Pharmaceuticals
Description
LuciTofa is a generic 5 mg tofacitinib citrate tablet used to treat inflammatory conditions. The manufacturer provides product documentation in the Thai language to support patients in the region.
Best for
Southeast Asian patients, localized documentation and autoimmune treatment
Rating
Source: Lucius Pharmaceuticals (Lao) Co., Ltd.
Description
LuciTofa is a Janus kinase (JAK) inhibitor containing Tofacitinib (5mg) in film-coated tablet form. This pharmaceutical product is used for the treatment of adult patients with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It specifically targets the JAK1 and JAK3 enzymes to block signaling pathways for pro-inflammatory cytokines, making it a key treatment option for those with inadequate responses to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Best for
rheumatoid arthritis treatment, psoriatic arthritis management, ulcerative colitis patients and JAK inhibitor therapy
Rating
Source: Lucius Pharmaceuticals
Description
LuciTofa is a tofacitinib generic with local registration in Thailand (08 ล 1185/24). It is indicated for rheumatoid and psoriatic arthritis, offering a locally available alternative to cross-border brands like Tofacinix.
Best for
local Thai pharmacy users, arthritis management, registered generic drugs and rheumatology clinic patients
Rating
| Compare | LuciTofa | LuciTofa | LuciTofa 5 mg |
|---|---|---|---|
| Source | Lucius Pharmaceuticals | Lucius Pharmaceuticals (Lao) Co., Ltd. | Lucius Pharmaceuticals |
| Description | LuciTofa is a generic 5 mg tofacitinib citrate tablet used to treat inflammatory conditions. The manufacturer provides product documentation in the Thai language to support patients in the region. | LuciTofa is a Janus kinase (JAK) inhibitor containing Tofacitinib (5mg) in film-coated tablet form. This pharmaceutical product is used for the treatment of adult patients with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It specifically targets the JAK1 and JAK3 enzymes to block signaling pathways for pro-inflammatory cytokines, making it a key treatment option for those with inadequate responses to methotrexate or other disease-modifying antirheumatic drugs (DMARDs). | LuciTofa is a tofacitinib generic with local registration in Thailand (08 ล 1185/24). It is indicated for rheumatoid and psoriatic arthritis, offering a locally available alternative to cross-border brands like Tofacinix. |
| Best for | Southeast Asian patients, localized documentation and autoimmune treatment | rheumatoid arthritis treatment, psoriatic arthritis management, ulcerative colitis patients and JAK inhibitor therapy | local Thai pharmacy users, arthritis management, registered generic drugs and rheumatology clinic patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"LuciTofa from Lucius Pharmaceuticals."
I picked this because Regional availability with localized documentation makes it a accessible generic option for patients in the Thai region.